http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8402192-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d9f3ca41550d315642580237250c5b0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-144444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2333-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J5-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J5-18 |
| filingDate | 1983-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa6f5f187d3aad129c3af4627a7647d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c9570b154689939fee5d3245df1df4 |
| publicationDate | 1984-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-8402192-A1 |
| titleOfInvention | Analytical element containing a barrier zone and process employing same |
| abstract | Multizone element, for quantitative analyte determination in whole blood, containing a porous spreading zone separated from a reagent zone by a barrier zone, said barrier zone comprising a non-porous film comprising a polymer of: from 30 to 95 percent by weight of polymerized monomer having the structure from (I) 0.25 to 30 percent by weight of polymerized monomer having the structure (II) from 0.1 to 50 percent by weight of polymerized monomer having the structure (III) wherein: R1, R3, and R5 are independently selected from the group consisting of hydrogen and methyl, R2is alkyl of from 1 to 16 carbon atoms, R4 and R6 are independently selected from the group consisting of alkylene groups having from 1 to 6 carbon atoms, (IV) wherein R7 is hydrogen, alkyl of 1 to 10 carbon atoms, or cycloalkyl of 5 to 10 carbon atoms, and M is NR8R9H+X or SO3-X wherein R8 and R9 are independently selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms and X is a counterion. A process for employing the element in analyses for analytes in whole blood is also disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0229721-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0302287-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0302287-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5169787-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0229721-A2 |
| priorityDate | 1982-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.